Unpacking the FDA’s Sweeping Proposal to Move All Drugs to OTC
About this episode
Mark Garofoli discusses the FDA's proposal to move all drugs to OTC and its implications for the pharmacy profession.
Mark Garofoli, PharmD, BCGP, CPE, CTTS, joins Over the Counter to discuss recent comments from FDA Commissioner Marty Makary, MD, MPH, and what they could mean for the pharmacy profession going forward.
More episodes of Over the Counter
- The Pharmacy Rewards Program Improving Outcomes Through Key Partnerships
- Pharmacy Accreditation Requires Ongoing Diligence for Network Access
- What Pharmacies Need to Know About FDA Shift to 12-Digit NDCs
- What the Walgreens ‘Hybrid Pharmacist’ Role is Doing for Workforces Challenges
- How Weight-Loss Drugs Could Reshape the Landscape of Addiction Treatment
- Diabetes Alert Day: The Pharmacist’s Powerful Role in Diabetes Care
Explore listener stats, chart rankings, contacts and more on the Over the Counter podcast page.